Clinical trial · Observational
Fitness in Elderly AML Patients
Multicenter Retrospective Observational Study to Verify the Application of SIE/SIES/GITMO FITNESS CRITERIA to Guide Therapeutic Choice in Elderly Patients With Acute Myeloid Leukemia in Light of the Availability of New Drugs - AML FITNESS
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aims to evaluate the outcome of patients (overall survival) who received treatments commensurate with the proposed "Fitness" parameters compared to that of patients whose treatment differed either in the direction of greater or lesser aggressiveness than that proposed (evaluation of survival through Kaplan-Meier analysis and comparison with the log-rank test).
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| AML (Acute Myelogenous Leukemia | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Fitness Categories: FIT, UNFIT and FRAIL | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- elderly aml patients
- interventionNames
- Other: Fitness Categories: FIT, UNFIT and FRAIL
Primary outcomes (1)
- measure
- overall survival according to fitness categories and treatment received
- timeFrame
- "From enrollment to the end of treatment at 12 months"
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
Acute Myeloid Leukemia Diagnosis no Acute Promyelocytic Leukemia aged more than 65 years
References
Publications (0)
Data not yet available